Genetic Modification of T Lymphocytes for Adoptive Immunotherapy

This publication has 137 references indexed in Scilit:

• A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
  New England Journal of Medicine, 2003
• Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes
  Nature Biotechnology, 2002
• Transforming growth factor-β in T-cell biology
  Nature Reviews Immunology, 2002
• Retroviral Transduction of a T Cell Receptor Specific for an Epstein–Barr Virus-Encoded Peptide
  Clinical Immunology, 2001
• Retrovirus-Mediated Gene Transfer in Primary T Lymphocytes: Influence of the Transduction/Selection Process and ofex VivoExpansion on the T Cell Receptor β Chain Hypervariable Region Repertoire
  Human Gene Therapy, 2000
• The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
  Science, 1999
• Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120
  European Journal of Immunology, 1998
• In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors.
  Journal of Clinical Investigation, 1998
• The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways
  Cell, 1991
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988